DE60028593D1 - Perkutane absorptionsbeschleuniger für die elektroporation - Google Patents

Perkutane absorptionsbeschleuniger für die elektroporation

Info

Publication number
DE60028593D1
DE60028593D1 DE60028593T DE60028593T DE60028593D1 DE 60028593 D1 DE60028593 D1 DE 60028593D1 DE 60028593 T DE60028593 T DE 60028593T DE 60028593 T DE60028593 T DE 60028593T DE 60028593 D1 DE60028593 D1 DE 60028593D1
Authority
DE
Germany
Prior art keywords
electroporation
percutanean
absorption accelerator
percutaneous
sorbefacients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60028593T
Other languages
English (en)
Other versions
DE60028593T2 (de
Inventor
Yoshihiro Tokudome
Koji Owaku
Kenichi Goto
Kenji Sugibayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pola Orbis Holdings Inc
Original Assignee
Pola Chemical Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Chemical Industries Inc filed Critical Pola Chemical Industries Inc
Application granted granted Critical
Publication of DE60028593D1 publication Critical patent/DE60028593D1/de
Publication of DE60028593T2 publication Critical patent/DE60028593T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60028593T 1999-10-15 2000-04-06 Perkutane absorptionsbeschleuniger für die elektroporation Expired - Fee Related DE60028593T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP29324099 1999-10-15
JP29324099 1999-10-15
PCT/JP2000/002244 WO2001026688A1 (fr) 1999-10-15 2000-04-06 Promoteurs d'absorption percutanee pour electroporation

Publications (2)

Publication Number Publication Date
DE60028593D1 true DE60028593D1 (de) 2006-07-20
DE60028593T2 DE60028593T2 (de) 2007-01-25

Family

ID=17792260

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60028593T Expired - Fee Related DE60028593T2 (de) 1999-10-15 2000-04-06 Perkutane absorptionsbeschleuniger für die elektroporation

Country Status (8)

Country Link
US (1) US6721595B1 (de)
EP (1) EP1222931B1 (de)
JP (1) JP4871469B2 (de)
AT (1) ATE328581T1 (de)
AU (1) AU3672100A (de)
CA (1) CA2387370C (de)
DE (1) DE60028593T2 (de)
WO (1) WO2001026688A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2005094814A1 (ja) * 2004-03-31 2008-02-14 興和株式会社 外用剤
WO2008106646A2 (en) * 2007-03-01 2008-09-04 Introgen Therapeutics, Inc Methods and formulations for topical gene therapy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0398960B1 (de) * 1988-01-21 1995-12-06 Massachusetts Institute Of Technology Molekültransport durch gewebe mit der verwendung von elektroporation
AU7547891A (en) * 1990-03-30 1991-10-30 Yasunori Morimoto Percutaneously absorbable composition of narcotic and nonnarcotic analgesics
JPH0616538A (ja) * 1992-07-03 1994-01-25 Japan Tobacco Inc イオントフォレーゼのための薬物吸収用液組成物
JP3908795B2 (ja) * 1994-11-29 2007-04-25 久光製薬株式会社 ケトチフェン含有経皮投与製剤
US5990179A (en) * 1995-04-28 1999-11-23 Alza Corporation Composition and method of enhancing electrotransport agent delivery
JP3898250B2 (ja) * 1996-03-26 2007-03-28 久光製薬株式会社 エレクトロポレーション用マイクロエマルション製剤
US6266560B1 (en) * 1998-06-19 2001-07-24 Genetronics, Inc. Electrically assisted transdermal method and apparatus for the treatment of erectile dysfunction
JP2002527488A (ja) * 1998-10-16 2002-08-27 ノボ ノルディスク アクティーゼルスカブ メントールを含有する肺送達のためのインスリン製剤
ATE354376T1 (de) * 1999-10-14 2007-03-15 Pola Chem Ind Inc Zusammensetzungen für die elektroporation

Also Published As

Publication number Publication date
EP1222931B1 (de) 2006-06-07
DE60028593T2 (de) 2007-01-25
CA2387370A1 (en) 2001-04-19
EP1222931A1 (de) 2002-07-17
EP1222931A4 (de) 2005-03-23
AU3672100A (en) 2001-04-23
ATE328581T1 (de) 2006-06-15
JP4871469B2 (ja) 2012-02-08
WO2001026688A1 (fr) 2001-04-19
US6721595B1 (en) 2004-04-13
CA2387370C (en) 2008-12-23

Similar Documents

Publication Publication Date Title
PL1841743T3 (pl) Amidy kwasu 3-arylo-3-hydroksy-2-aminopropionowego, amidy kwasu 3-heteroarylo-3-hydroksy-2-aminopropionowego i powiązane związki o działaniu przeciwbólowym i/lub immunostymulacyjnym
AU7779900A (en) Trifluoromethyl-substituted spirocyclic ketoenols
BR0210519A (pt) Composições farmacêuticas de adsorvatos de fármaco amorfo
EP2505207A3 (de) Modifizierte Exendine und Anwendungen davon
WO2004062613A3 (en) Hiv integrase inhibitors
PT1017659E (pt) Tetra-hidronaftalenos substituidos e compostos analogos
DE50004443D1 (de) Wirkstoffhaltige komposition sowie deren herstellung und verwendung
AU3287200A (en) Composition comprising isoquercetin and ascorbic acid in a sustained release form
AU2003273869A1 (en) Stable polyurethane systems
ATE164159T1 (de) Substituierte triole
WO2003066587A3 (en) Piperidine or pyrrolidine derivatives having an aminoacyl substituted side chain as melancortin-4 receptor agonists
DE60113445D1 (de) Substanzen mit verzweigten linkermolekülen
ATE344055T1 (de) Zusammensetzungen für die elektroporation
TW200609226A (en) New isobenzoxazinones and their use as ultraviolet light absorbers
CY1109541T1 (el) Φαρμακευτικη συνταγοποιηση για την θεραπεια οστεοαρθριτιδας η οποια περιεχει κλοδρονικο οξυ και υαλουρονικο οξυ
DE60008400D1 (de) Triazolopyrimidinderivate
SE0004054D0 (sv) N-type calcium channel antagonists for the treatment of pain
WO2007031557A3 (en) Alcanoic acid amides substituted by saturated o-heterocycles
BR0309996A (pt) Composto, composição farmacêutica, método de tratar ou melhorar doenças ou condições proliferativas, uso de um composto, e, método de tratar ou melhorar doenças inflamatórias
GEP20074075B (en) Indazolamides with analgesic activity
DE60001366D1 (de) Orale zusammensetzung enthaltend perlit
DE60028593D1 (de) Perkutane absorptionsbeschleuniger für die elektroporation
DE50307423D1 (de) Kationische polymerisate und deren verwendung in kosmetischen formulierungen
DE60231385D1 (de) Formulierungen, die eingeschlossene wirkstoffe enthalten, und ihre verwendung
WO2007022734A8 (fr) Composition destinee a soulager la gueule de bois comprenant de l'acide hyaluronique et du charbon active

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee